ZICX:OTO-Zicix Corporation (USD)

COMMON STOCK | Software - Application | OTC Pink

Last Closing

USD 0.0006

Change

0.00 (0.00)%

Market Cap

USD 0.02B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Zicix Corp provides medical diagnostic services.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-16 )

Largest Industry Peers for Software - Application

Symbol Name Price(Change) Market Cap
SAPGF SAP SE

+2.35 (+1.22%)

USD 225.40B
CNSWF Constellation Software Inc

+10.47 (+0.37%)

USD 58.75B
DASTF Dassault Systemes SE

N/A

USD 56.57B
DASTY Dassault Systemes SA

+0.45 (+1.21%)

USD 50.52B
WTCHF WiseTech Global Limited

N/A

USD 21.67B
DIDIY Didi Global Inc ADR

N/A

USD 21.55B
SGGEF The Sage Group plc

+0.01 (+0.04%)

USD 13.96B
XROLF Xero Limited

-0.40 (-0.45%)

USD 13.95B
SGPYY Sage Group PLC ADR

+0.70 (+1.28%)

USD 13.62B
NEMTF Nemetschek SE

N/A

USD 12.22B

ETFs Containing ZICX

ZMU:CA BMO Mid-Term US IG Corpor.. 0.00 % 0.27 %

+0.02 (+0.16%)

CAD 2.79B

Market Performance

  Market Performance vs. Industry/Classification (Software - Application) Market Performance vs. Exchange (OTC Pink)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -33.33% 28% F 18% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -33.33% 28% F 18% F
Trailing 12 Months  
Capital Gain -40.00% 39% F 28% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -40.00% 39% F 28% F
Trailing 5 Years  
Capital Gain -97.39% 28% F 12% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -97.39% 28% F 12% F
Average Annual (5 Year Horizon)  
Capital Gain -35.04% 10% F 5% F
Dividend Return -35.04% 10% F 5% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 52.12% 63% D 48% F
Risk Adjusted Return -67.24% 14% F 11% F
Market Capitalization 0.02B 24% F 15% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative earnings

The company had negative total earnings in the most recent four quarters.